5 biggest new drugs approved in 2019 so far
Questions pile up for Novartis as senators call on FDA to take action
Lilly’s Taltz bests JNJ rival Tremfya in psoriasis
Daiichi Sankyo cutting opioid sales jobs
*scroll through previous pages at the bottom to get older news*
Want to stay updated on CP happenings? New features, new boards, CP wire articles, and more? Click here to subscribe
